SEC Form 4 · accession 0001209191-16-106624
TREVENA INC · TRVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Soergel
Officer — Sr. VP,Clinical Dev. & CMO
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429560
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $8.82 | Mar 3, 2016 | A | 105,000 | A | — | Mar 3, 2026 | Common Stock | 105,000 | 105,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of March 3, 2017, March 3, 2018, March 3, 2019 and March 3, 2020, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date.